Literature DB >> 2508630

Kinetic analysis of the interaction of alkyl glycosides with two human beta-glucosidases.

V Gopalan1, L B Daniels, R H Glew, M Claeyssens.   

Abstract

This paper addresses the similarities and differences in the topology of the catalytic centres of human liver cytosolic beta-glucosidase and placental lysosomal glucocerebrosidase, and utilizes well-documented reversible active-site-directed inhibitors. This comparative kinetic study was performed mainly to decipher the chemical and structural nature of the active site of the cytosolic beta-glucosidase, whose physiological function is unknown. Specifically, analysis of the effects of a family of alkyl beta-glucosides consistently displayed 100-250-fold lower inhibition constants with the cytosolic broad-specificity beta-glucosidase compared with the placental glucocerebrosidase; for example, with octyl beta-D-glucoside the Ki values were 10 microM and 1490 microM for the cytosolic and lysosomal beta-glucosidases respectively. Furthermore the higher affinity of the cytosolic beta-glucosidase than glucocerebrosidase for the amphipathic alkyl beta-D-glucosides was validated by the greater increase in the free energy of binding with increasing alkyl chain length [delta delta G0 (K,)/CH2: lysosomal enzyme, 2.01 kJ/mol (480 cal/mol); cytosolic enzyme, 3.05 kJ/mol (730 cal/mol)]. The implications of the presence of highly non-polar domains in the active site of the cytosolic beta-glucosidase are discussed with regard to its potential physiological substrates.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2508630      PMCID: PMC1133302          DOI: 10.1042/bj2620541

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  15 in total

1.  Binding of alkyl 1-thio-beta-D-galactopyranosides to beta-D-galactosidase from E. coli.

Authors:  C K De Bruyne; M Yde
Journal:  Carbohydr Res       Date:  1977-06       Impact factor: 2.104

2.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

3.  Isolation of a cytosolic beta-glucosidase from calf liver and characterization of its active site with alkyl glucosides and basic glycosyl derivatives.

Authors:  G Legler; E Bieberich
Journal:  Arch Biochem Biophys       Date:  1988-01       Impact factor: 4.013

4.  Steroid estrogen glycosides. Formation of glucosides and galactosides by human liver and kidney.

Authors:  D G Williamson; D S Layne; D C Collins
Journal:  J Biol Chem       Date:  1972-05-25       Impact factor: 5.157

5.  A microassay for Gaucher's disease.

Authors:  S P Peters; R E Lee; R H Glew
Journal:  Clin Chim Acta       Date:  1975-05-01       Impact factor: 3.786

6.  Purification and characterization of a cytosolic broad specificity beta-glucosidase from human liver.

Authors:  L B Daniels; P J Coyle; Y B Chiao; R H Glew; R S Labow
Journal:  J Biol Chem       Date:  1981-12-25       Impact factor: 5.157

7.  beta-Glucosidase assays in the diagnosis of Gaucher's disease.

Authors:  L B Daniels; R H Glew
Journal:  Clin Chem       Date:  1982-04       Impact factor: 8.327

8.  Statistical analysis of enzyme kinetic data.

Authors:  W W Cleland
Journal:  Methods Enzymol       Date:  1979       Impact factor: 1.600

9.  beta-D-xylosidase from Penicillium wortmanni: binding and hydrolysis of alkyl and aryl 1-oxygen and 1-thio-beta-D-xylopyranosides.

Authors:  F Deleyn; M Claeyssens; C K De Bruyne
Journal:  Can J Biochem       Date:  1980-01

10.  Galactosylsphingosine inhibition of the broad-specificity cytosolic beta-glucosidase of human liver.

Authors:  K L LaMarco; R H Glew
Journal:  Arch Biochem Biophys       Date:  1985-02-01       Impact factor: 4.013

View more
  1 in total

1.  Substrate (aglycone) specificity of human cytosolic beta-glucosidase.

Authors:  Jean-Guy Berrin; Mirjam Czjzek; Paul A Kroon; W Russell McLauchlan; Antoine Puigserver; Gary Williamson; Nathalie Juge
Journal:  Biochem J       Date:  2003-07-01       Impact factor: 3.857

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.